Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Selskabet af 12. september 2022 A/S
A/S
In liquidation
CVR 29195633
Silkeborgvej 2, 8000
Aarhus C
Forskning og eksperimentel udvikling indenfor bioteknologi
· NACE 721100
Est. 2005
1 employees
Watchlist
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
Selskabet af 12. september 2022 A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (6)
FN
Finn Nielsen
Management
Management
2016 – 2020
SS
Søren Stæhr
Unofficial title
Unofficial title
2022 – 2022
BG
Bent Gadgaard
Chief Executive Officer
Chief Executive Officer
2006 – 2015
LS
Lars Spicker Olesen
Management
Management
2020 – 2022
PA
Peter Andreas Stakemann
Management
Management
2005 – 2005
CB
Christian Bak Hartvig
Management
Management
2005 – 2006
Board of directors
Non-executive oversight
Name
Role
Member since
Former (17)
TD
Tommy Due Høy
Chairman
2020 – 2022
LA
Lars Aagaard Nielsen
Chairman
2015 – 2016
AS
Allan Skovgaard
Board of Directors
2015 – 2019
JH
Jørgen Herman Melchior
Chairman
2005 – 2005
HK
Helle Kidmose
Board of Directors
2012 – 2015
HS
Henning Sandager Andersen
Chairman
2012 – 2014
LA
Lone Annette Saul Stakemann
Board of Directors
2005 – 2005
JL
Jens Lübeck Johansen
Chairman
2006 – 2007
JM
Jørgen Melgaard Pedersen
Board of Directors
2006 – 2009
DK
Dorthe Kling Zinck
Board of Directors
2005 – 2006
PS
Poul Schwartz Madsen
Chairman
2016 – 2019
MF
Mads Flemming Prebensen
Chairman
2007 – 2012
SW
Søren Wulff Sørensen
Board of Directors
2009 – 2012
TS
Thorbjørn Stuhde Machholm
Board of Directors
2015 – 2016
TR
Thomas Rosenkilde Anderson
Chairman
2019 – 2020
AN
Astrid Nørgaard Friis
Board of Directors
2020 – 2022
MP
Michael Pedersen
Chairman
2005 – 2006
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
GRUNDFOS HOLDING A/S
Company
100%
100%
2009
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Selskabet af 12. september 2022 A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network